Signs of Rising Above Expectations
Palomar Holdings Inc (Symbol: PLMR) has recently outperformed the average analyst 12-month target price of $81.67, trading at $82.64/share. When a stock hits its target price, analysts are faced with a pivotal choice: downgrade or lift the target price. The decision hinges on the company’s underlying business dynamics driving the stock up — a clear indicator for a potential target price adjustment.
Diverse Analyst Perspectives Unveiled
Within the Zacks coverage realm, 6 different analysts contribute to Palomar Holdings’ average target price. However, this average is just a numerical aggregate. Analysts hold varying target prices, ranging from as low as $68.00 to as high as $88.00, with a standard deviation of $7.814.
The rationale behind scrutinizing the average PLMR price target lies in tapping into the collective intelligence of the market — an amalgamation of various expert opinions rather than relying solely on individual perspectives. With PLMR surpassing the average target price of $81.67/share, investors receive a clear signal to reevaluate the company and ponder whether $81.67 is merely a stepping stone to an even higher target or if the valuation has stretched too far, prompting a prudent consideration.
| Recent PLMR Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago |
| Strong buy ratings: | 5 | 4 | 4 | 5 |
| Buy ratings: | 1 | 1 | 1 | 1 |
| Hold ratings: | 3 | 4 | 4 | 4 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.78 | 2.0 | 2.0 | 1.9 |
The average rating in the table above ranges from 1 to 5, where 1 signifies Strong Buy and 5 denotes Strong Sell. Data utilized in this article is sourced from Zacks Investment Research via Quandl.com.
The Top 25 Broker Analyst Picks of the S&P 500 »
Also see:
BankInvestor
KYE Insider Buying
Acrivon Therapeutics Past Earnings
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
